{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:57:21Z","timestamp":1793451441632,"version":"4.5.0"},"reference-count":36,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Lysyl oxidase (LOX) is a secretory protein that catalyzes elastin and collagen cross-linking. Lowering LOX expression and activity in endothelial cells is associated with a high risk of aneurysms and vascular malformation. Interleukin-6 (IL-6), elevated in hypertension, is known to suppress LOX expression. The influence of anti-hypertensive medication on the plasma LOX concentration is currently unknown. In a cohort of 34 patients diagnosed with resistant hypertension and treated with up to nine different drugs, blood concentration of LOX was analyzed to identify drugs that have an impact on plasma LOX concentration. Key findings were confirmed in a second independent patient cohort of 37 patients diagnosed with dilated cardiomyopathy. Blood concentrations of aldosterone and IL-6 were analyzed. In vitro, the effect of IL-6 on LOX expression was analyzed in endothelial cells. Patients receiving aldosterone antagonists had the highest plasma LOX concentration in both cohorts. This effect was independent of sex, age, blood pressure, body mass index, and co-medication. Blood aldosterone concentration correlates with plasma IL-6 concentration. In vitro, IL-6 decreased the expression of LOX in endothelial cells but not fibroblasts. Aldosterone was identified as a factor that affects blood concentration of LOX in an IL-6-dependent manner.<\/jats:p>","DOI":"10.3390\/biomedicines10071748","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T11:22:24Z","timestamp":1658316144000},"page":"1748","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Anti-Hypertensive Medication on Plasma Concentrations of Lysyl Oxidase: Evidence for Aldosterone-IL-6-Dependent Regulation of Lysyl Oxidase Blood Concentration"],"prefix":"10.3390","volume":"10","author":[{"given":"Rolf","family":"Schreckenberg","sequence":"first","affiliation":[{"name":"Institute of Physiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"D\u00f6rr","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pankuweit","sequence":"additional","affiliation":[{"name":"Department Internal Medicine-Cardiology, Philipps-University of Marburg, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Schieffer","sequence":"additional","affiliation":[{"name":"Department Internal Medicine-Cardiology, Philipps-University of Marburg, 35043 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Troidl","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Nef","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Hamm","sequence":"additional","affiliation":[{"name":"Department of Cardiology, JLU Giessen, 35390 Giessen, Germany"},{"name":"Department of Cardiology, Kerckhoff Heart and Thorax Center, 61231 Bad Nauheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-5221","authenticated-orcid":false,"given":"Susanne","family":"Rohrbach","sequence":"additional","affiliation":[{"name":"Institute of Physiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Physiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6093-4919","authenticated-orcid":false,"given":"Klaus-Dieter","family":"Schl\u00fcter","sequence":"additional","affiliation":[{"name":"Institute of Physiology, JLU Giessen, 35390 Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mce.2016.03.038","article-title":"TRAF3IP2 mediates aldosterone\/salt-induced cardiac hypertrophy and fibrosis","volume":"429","author":"Sakamuri","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fphys.2017.00556","article-title":"Effects of 6 months\u2018 exercise on cardiac function, structure, and metabolism in female hypertensive rats\u2013the decisive role of lysyl oxidase and collagen III","volume":"8","author":"Schreckenberg","year":"2017","journal-title":"Front. Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.5665\/sleep.5052","article-title":"Lysyl oxidase as a biomarker of liver fibrosis in patients with severe obesity and obstructive sleep apnea","volume":"38","author":"Mesarwi","year":"2015","journal-title":"Sleep"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Eberson, L.S., Sanchez, P.A., Majeed, B.A., Tawinwung, S., Secomb, T.W., and Larson, D.F. (2015). Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0124013"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCRESAHA.116.304918","article-title":"Adventitial CXCL1\/G-CSF expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture","volume":"116","author":"Anzai","year":"2015","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.117.09822","article-title":"Vascular ADAM17 (a disintegrin and metalloproteinase domain 17) is required for angiotensin II\/\u03b2-aminopropionitrile-induced abdominal aortic aneurysm","volume":"70","author":"Kawai","year":"2017","journal-title":"Hypertension"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"H1067","DOI":"10.1152\/ajpheart.00217.2012","article-title":"The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysm","volume":"303","author":"Remus","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/cvr\/cvn102","article-title":"Regulation of lysyl oxidase in vascular cells: Lysyl oxidase as a new player in cardiovascular disease","volume":"79","author":"Rodriguez","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2017.04.011","article-title":"The influence of chronic IL-6 exposure, in vivo, on rat achilles tendon extracellular matrix","volume":"93","author":"Katsma","year":"2017","journal-title":"Cytokine"},{"key":"ref_10","first-page":"12","article-title":"Attenuation of lysyl oxidase and collagen gene expression in keratoconus patient corneal epithelium corresponds to disease severity","volume":"21","author":"Shetty","year":"2015","journal-title":"Mol. Vis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.2741\/2879","article-title":"Lysyl oxidase and endothelial dysfunction: Mechanimsm of lysly oxidase down-regulation by pro-inflammatory cytokines","volume":"13","author":"Alcudia","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1253\/circj.72.293","article-title":"Association between blood pressure variability and inflammatory marker in hypertensive patients","volume":"72","author":"Kim","year":"2008","journal-title":"Circ. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/01.HYP.0000139913.56461.fb","article-title":"Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice","volume":"44","author":"Lee","year":"2004","journal-title":"Hypertension"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jir.2010.0036","article-title":"Genetic and environmental influences on the plasma interleukin-6 concentration in patients with a recent myocardial infarction: A case control study","volume":"31","author":"Bennermo","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10157-010-0334-8","article-title":"Association between cytostatin C and inflammation in patients with essential hypertension","volume":"14","author":"Okura","year":"2010","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"H111","DOI":"10.1152\/ajpheart.01061.2003","article-title":"Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: Role of NFkappaB\/IkappaB system","volume":"288","author":"Oubina","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.jhh.1001537","article-title":"Inflammation, endothelial dysfunction, and the risk of high blood pressure: Epidemiologic and biological evidence","volume":"17","author":"Bautista","year":"2013","journal-title":"J. Hum. Hypertens."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/CS20120619","article-title":"N-Acetyl-Seryl-Aspartyl-Lysyl-Proline reduces cardiac collagen cross-linking and inflammation in angiotensin II induced hypertensive rats","volume":"126","author":"Gonzalez","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24690","DOI":"10.1074\/jbc.M412979200","article-title":"Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation","volume":"280","author":"Fogelgren","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_21","first-page":"H1462","article-title":"Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers","volume":"268","author":"Noll","year":"1995","journal-title":"Am. J. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1161\/CIRCULATIONAHA.119.044986","article-title":"Lysyl oxidase inhibition ablates sexual dimorphism of abdominal aortic aneurysm formation in mice","volume":"142","author":"Okuyama","year":"2020","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/aja.aja_8_17","article-title":"Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NFkB pathway","volume":"20","author":"Wu","year":"2018","journal-title":"Asian J. Androl."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cvr\/cvy013","article-title":"IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis","volume":"114","author":"Chou","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.cellsig.2015.07.001","article-title":"Aldosterone-induced cardiomyocytes growth, and fibroblast migration and proliferation are mediated by TRAF3IP2","volume":"27","author":"Somanna","year":"2015","journal-title":"Cell Signal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1161\/01.ATV.0000033818.21748.99","article-title":"Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall","volume":"22","author":"Rodriguez","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2004.06.015","article-title":"High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells","volume":"177","author":"Raposo","year":"2004","journal-title":"Atherosclerosis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1902\/jop.2002.73.2.145","article-title":"Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin","volume":"73","author":"Hong","year":"2002","journal-title":"J. Periodontol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2230.2004.01473.x","article-title":"The role of ascorbic acid on collagen structure and levels of serum interleukin-6 and tumor necrosis factor-alpha in experimental lathyrism","volume":"29","author":"Senturk","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1074\/jbc.M110.166181","article-title":"Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation","volume":"286","author":"Thaler","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Chang, Y., Li, Y., Guo, X., Chen, Y., Dai, D., and Sun, Y. (2017). The prevalence of hypertension accompanied by high homocysteine and its risk factors in a rural population: A croos-sectional study from northeast China. Int. J. Environ. Res. Public Health, 14.","DOI":"10.3390\/ijerph14040376"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1210\/jcem.86.3.7305","article-title":"Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women","volume":"86","author":"Vayreda","year":"2001","journal-title":"J. Clin. Endocrin. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/HYPERTENSIONAHA.106.084103","article-title":"Decreased endogenous level of Ac-SDKP promote organ fibrosis","volume":"50","author":"Cavasin","year":"2007","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/cvr\/cvp136","article-title":"Statins normalize vascular lysyl oxidase down-regulation induced by pro-artherogenic risk factors","volume":"83","author":"Rodriguez","year":"2009","journal-title":"Cardiovasc. Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1748\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:54:44Z","timestamp":1760140484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["biomedicines10071748"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10071748","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]}}}